Compliance officers at firms were fretting over fears that new rules were looming in the U.S. over how structured products are sold to retail investors. [In June, the U.S. Financial Industry Regulatory Authority issued additional guidance in relation to sales practices for structured products in addition to a Q&A for broker dealers.]
